1. Ji, Yewei, Luo, Yuan, Wu, Yating, Liang, Tingbo, Qi, Ling. 2023. SEL1L-HRD1 endoplasmic reticulum-associated degradation controls STING-mediated innate immunity by limiting the size of the activable STING pool. In Nature cell biology, 25, 726-739. doi:10.1038/s41556-023-01138-4. https://pubmed.ncbi.nlm.nih.gov/37142791/
2. Gao, Yafeng, Li, Wenhui, Wang, Zhenghao, Zhang, Baojun, Zhang, Lianjun. 2023. SEL1L preserves CD8+ T-cell survival and homeostasis by fine-tuning PERK signaling and the IL-15 receptor-mediated mTORC1 axis. In Cellular & molecular immunology, 20, 1232-1250. doi:10.1038/s41423-023-01078-x. https://pubmed.ncbi.nlm.nih.gov/37644166/
3. Ahmed, Sharif, Habu, Toshiyuki, Kim, Jiyeong, Koizumi, Akio, Kobayashi, Hatasu. 2022. Suppression of RNF213, a susceptibility gene for moyamoya disease, inhibits endoplasmic reticulum stress through SEL1L upregulation. In Biochemical and biophysical research communications, 609, 62-68. doi:10.1016/j.bbrc.2022.04.007. https://pubmed.ncbi.nlm.nih.gov/35413541/
4. Wang, Jinyu, Li, Jing, Wu, Jingwen, Lu, Mengji, Zhang, Jiming. 2019. Host Gene SEL1L Involved in Endoplasmic Reticulum-Associated Degradation Pathway Could Inhibit Hepatitis B Virus at RNA, DNA, and Protein Levels. In Frontiers in microbiology, 10, 2869. doi:10.3389/fmicb.2019.02869. https://pubmed.ncbi.nlm.nih.gov/31921048/
5. Pociot, F, Larsen, Z M, Zavattari, P, Biunno, I, Cucca, F. . No evidence for SEL1L as a candidate gene for IDDM11-conferred susceptibility. In Diabetes/metabolism research and reviews, 17, 292-5. doi:. https://pubmed.ncbi.nlm.nih.gov/11544613/
智鼠故事 
